{"entity":{"id":"nct07161791","kind":"trial","name":"Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer","aka":[],"tldr":"A phase 1/2 trial in triple-negative breast cancer, run by Harbin Medical University, not yet recruiting.","summary":"Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer is a phase 1/2, interventional study registered as NCT07161791 by Harbin Medical University, with a registry enrolment figure of 12 participants, started 2025-09-15 and due to reach its primary completion in 2026-12-31. Interventions recorded: Camrelizumab Combined With Pirfenidone and Chemotherapy. Conditions listed: Breast Cancer; Triple Negative Breast Cancer (TNBC). Triple-negative eligibility wording from the registry: \"* Histologically confirmed recurrent/metastatic TNBC (ER-negative: IHC ER \\<1%; PR-negative: IHC PR \\<1%; HER2-negative: IHC -/+, or IHC ++ but FISH/CISH negative), with at least one measurable lesion per RECIST v1\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07161791","url":"https://clinicaltrials.gov/study/NCT07161791"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07161791","phase":"1/2","setting":"Exploratory Clinical Study of Camrelizumab Combined With Pirfenidone and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer","sponsor":"Harbin Medical University","enrolled":12,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07161791/","neighbours":{"cancer":[{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}